Support Centre
25 October 2014 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Find trials
ISRCTN Register
tips on searching

New application
Updating record

governing board
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Research demonstration projects in mental health and homelessness
DOI 10.1186/ISRCTN42520374
ClinicalTrials.gov identifier
EudraCT number
Public title Research demonstration projects in mental health and homelessness
Scientific title Multi-site pragmatic randomised controlled field trial of Housing First versus treatment as usual in mental health and homelessness
Acronym N/A
Serial number at source N/A
Study hypothesis What is the effectiveness, cost/benefit, and cost/effectiveness of Housing First in comparison to care as usual for homeless adults?
Lay summary Not provided at time of registration
Ethics approval Pending as of 08/06/2009 from the Centre for Addiction and Mental Health Research Ethics Board (CAMH REB); expected in Autumn 2009 after each of five primary data collection sites have obtained ethics approval.
Study design Multi-method multi-site unblinded randomised controlled field trial
Countries of recruitment Canada
Disease/condition/study domain Homelessness and serious mental illness
Participants - inclusion criteria 1. Legal adult status
2. Absolute homelessness or precariously housed
3. Presence of a serious mental disorder
4. Aged 18 years and older, either sex
Participants - exclusion criteria Does not meet inclusion criteria
Anticipated start date 01/09/2009
Anticipated end date 01/04/2013
Status of trial Completed
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 2,225
Interventions Treatment: provision of rent supplements and case management or assertive community treatment for the duration of the study
Comparison: care as usual

Duration of intervention: Data collection will be ongoing from Sept 2009 to Feb 2013 with duration of intervention from 24 to 42 months.
Duration of follow-up: two years
Primary outcome measure(s) Housing Stability: Tsemberis Residential Timeline Follow-back Inventory, measured at 6, 12, 18 and 24 months.
Secondary outcome measure(s) Quality of Life: EQ-5D, measured at 6, 12, 18 and 24 months.
Sources of funding Health Canada (Canada)
Trial website
Publications 2012 results in: http://www.ncbi.nlm.nih.gov/pubmed/23031406
2012 childhood learning disability results in: http://www.ncbi.nlm.nih.gov/pubmed/23175737
2014 cumulative childhood adversity results in: http://www.ncbi.nlm.nih.gov/pubmed/24726046
2014 discrimination results in: http://www.ncbi.nlm.nih.gov/pubmed/25196184
Contact name Dr  Paula  Goering
  Address 33 Russell Street
  City/town Toronto, Ontario
  Zip/Postcode M5S 2S1
  Country Canada
  Tel +1 416 979 6844
  Fax +1 416 979 4703
  Email paula_goering@camh.net
Sponsor Mental Health Commission of Canada (Canada)
  Address attn Jayne Barker
10301 Southport Lane SW
  City/town Calgary
  Zip/Postcode T2W 1S7
  Country Canada
  Email jbarker@mentalhealthcommission.ca
  Sponsor website: http://www.mentalhealthcommissio.ca
Date applied 05/06/2009
Last edited 10/09/2014
Date ISRCTN assigned 18/08/2009
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2014 ISRCTN unless otherwise stated.